CHRU Tours - Hôpital Bretonneau
CHRU Tours - Hôpital Bretonneau
Tours, France3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Vaso-Occlusive Crises, acute chest syndrome, agnosia, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, lung disorder, nervous system disorder, perceptual disorders, respiratory system disorder, sickle cell disease | Recruiting | Phase 3 | 2026-09-09 | NCT07274254 | |
| SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer | Cancer of Oropharnyx, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, head and neck cancer, head and neck squamous cell carcinoma, neoplasm, oropharyngeal carcinoma, oropharynx squamous cell carcinoma, otorhinolaryngologic disease, squamous cell carcinoma | Not yet recruiting | Not applicable | 2026-07-21 | NCT07241273 | |
| Clonal Architecture of ASXL1-mutated Myelofibrosis | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis | Recruiting | Not applicable | 2026-03-09 | NCT05710211 |